HIV testing in Coventry, UK to become routine part of registering with GP

NewsGuard 100/100 Score

HIV testing in Coventry (UK) is to become a routine part of registering with a GP at ten surgeries across the city, which has the highest prevalence of the condition in the West Midlands.

All patients registering with the pilot surgeries will be offered a simple finger prick blood test, with results available in less than a minute.

The initiative, aimed at improving the early detection of the condition, is being led by a partnership involving Birmingham City University, the Integrated Sexual Health Service (Coventry and Warwickshire Partnership NHS Trust), Travel Klinix and Coventry City Council's Public Health Team.

More than three in every 1,000 people aged 15-59 years old in Coventry are diagnosed with HIV, while estimates for the UK suggest that over a quarter of people with the condition remain undiagnosed.

The National Institute for Health and Care Excellence (NICE) has recommended that all areas with an HIV prevalence of over two per 1,000 population should increase access to HIV testing.  One of those recommendations relates to increasing the number of HIV tests undertaken in primary care, as primary care professionals are in an ideal position to support the drive for early diagnosis of HIV.

The effectiveness of the pilot will be evaluated by researchers at Birmingham City University, who will explore the potential to expand the model more widely.

Dr Satyajit Das, Sexual Health Consultant at Coventry and Warwickshire Partnership NHS Trust, said: "Quite simply, HIV is not the illness it used to be. For thousands of people who have been given a positive diagnosis, HIV is now similar in many ways to other long-term conditions such as high blood pressure, but it is crucial that people come forward for testing. Medication is now very effective and most people don't realise that treatment can involve taking just one pill per day."

"Despite this we know that over half of all newly diagnosed patients in Coventry between 2011 and 2013 were diagnosed late, at a point at which they were much more likely to suffer severe complications or even, sadly, to die from the condition."

"The evidence is clear that early diagnosis has long-term health benefits, and also reduces transmission of HIV."

Professor Alex Kendall, Associate Dean of Research and Enterprise at Birmingham City University, said: "There are two key motivations behind this exciting initiative aimed at treating a condition that we know now is very effectively treatable. Firstly, we need to understand how effective offering this simple test is in reducing late diagnoses of HIV and secondly, we need to understand what people and health professionals think about offering testing in this way, in order to make sure we are offering the test in the right way."

Councillor Kamran Caan of Coventry City Council, added: "This is an exciting opportunity that we are seizing here in Coventry, not only to increase access to testing, but to change the way that HIV is perceived and challenge the myths and stigma that surround this illness. It is only this way that we will be able to successfully tackle the problem of people being diagnosed with HIV at a late stage and reduce the risk of the infection being passed on."  

Source: Birmingham City University

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New report on HIV drug resistance: Challenges and recommendations